Details for New Drug Application (NDA): 083889
✉ Email this page to a colleague
NDA 083889 describes METHAMPEX, which is a drug marketed by Teva and is included in one NDA. Additional details are available on the METHAMPEX profile page.
The generic ingredient in METHAMPEX is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
The generic ingredient in METHAMPEX is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
Summary for 083889
| Tradename: | METHAMPEX |
| Applicant: | Teva |
| Ingredient: | methamphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083889
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
